Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
AVNS · against 472 other Healthcare companies of similar size
Ranked #343 of 473 · scores higher than 28% of peers · safety percentile 31
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)38 peers with a safety percentile of 30–39, including AVNS · Click a bar to see the companies
Mainly because of its beta, which is weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | AVNS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 446 reported | 0.18× | 0.20× | 52% | 33% | |
| BetaLower is better · 446 reported | 1.57 | 0.48 | 9% | 33% | |
| Current ratioHigher is better · 459 reported | 2.48× | 2.84× | 46% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 1.5B USD | 100 | 44 | |
| 2 | 1.2B USD | 100 | 40 | |
| 3 | 1.1B USD | 100 | ||
| 4 | 1.0B USD | 99 | 35 | |
| 5 | 1.2B USD | 99 | ||
| 339 | 5.9B CNY (≈$823M) | 32 | 20 | |
| 340 | 1.3B USD | 31 | 20 | |
| 341 | 231.7B JPY (≈$1.6B) | 31 | 61 | |
| 342 | 1.6B USD | 31 | 30 | |
| 343 | 1.2B USD | 31 | ||
| 344 | 787M USD | 30 | 57 | |
| 345 | 1.7B USD | 30 | 35 | |
| 346 | 110.9B JPY (≈$754M) | 30 | 59 | |
| 347 | 101.2B JPY (≈$688M) | 29 | 54 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score